scholarly article | Q13442814 |
P356 | DOI | 10.1212/WNL.52.4.851 |
P698 | PubMed publication ID | 10078739 |
P2093 | author name string | J H Wokke | |
O P van Diggelen | |||
M G Ausems | |||
A J Reuser | |||
H K Ploos van Amstel | |||
P Lochman | |||
P433 | issue | 4 | |
P921 | main subject | glycogen storage disease | Q1421738 |
P304 | page(s) | 851-853 | |
P577 | publication date | 1999-03-01 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | A diagnostic protocol for adult-onset glycogen storage disease type II | |
P478 | volume | 52 |
Q42670535 | A point mutation in the UDP-glucose pyrophosphorylase gene results in decreases of UDP-glucose and inactivation of glycogen synthase. |
Q84971387 | Adult-Onset Acid Maltase Deficiency With Isolated Axial Muscle Involvement |
Q40413861 | Alkaptonuria and Pompe disease in one patient: metabolic and molecular analysis |
Q53915734 | Benign prognosis in idiopathic hyper-CK-emia. |
Q76380773 | Biopsy-proven alpha-glucosidase deficiency with normal lymphocyte enzyme activity |
Q42126616 | Clinical Analysis of Algerian Patients with Pompe Disease. |
Q21202855 | Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study |
Q34634354 | Consensus treatment recommendations for late-onset Pompe disease |
Q55066054 | Delayed diagnosis of late-onset Pompe disease in patients with myopathies of unknown origin and/or hyperCKemia. |
Q35809528 | Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group |
Q74552809 | Electrodiagnostic approach to the patient with suspected myopathy |
Q64050938 | Enzyme replacement therapy in juvenile glycogenosis type II: a longitudinal study |
Q38155413 | Extended phenotype description and new molecular findings in late onset glycogen storage disease type II: a northern Italy population study and review of the literature |
Q64378389 | Fully deleted adenovirus persistently expressing GAA accomplishes long-term skeletal muscle glycogen correction in tolerant and nontolerant GSD-II mice |
Q34098766 | Glycogen storage diseases: new perspectives |
Q34189319 | Hyper-CK-aemia revisited |
Q79252232 | Isolated elevated serum transaminases leading to the diagnosis of asymptomatic Pompe disease |
Q37031665 | Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting |
Q30840208 | Methods of diagnosis of patients with Pompe disease: Data from the Pompe Registry |
Q80411540 | Muscular glycogen storage diseases without increased glycogen content on histopathological examination |
Q34038884 | Phenotypic expression of late-onset glycogen storage disease type II: identification of asymptomatic adults through family studies and review of reported families |
Q34567528 | Pompe disease diagnosis and management guideline. |
Q79895239 | Seven cases of Pompe disease from Greece |
Q36245480 | The natural course of non-classic Pompe's disease; a review of 225 published cases |